Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion type Assertion NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_head.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion description "[Both T2DM and OB group had significantly increased serum concentrations of circulating proinflammatory factors (C-reactive protein, TNF?, IL-6, IL-8), mRNA expression of macrophage antigen CD68 and proinflammatory chemokines (CCL-2, -3, -7, -8, -17, -22) in SCAT and complementary chemokine receptors (CCR-1, -2, -3, -5) and other proinflammatory receptors (toll-like receptor 2 and 4, TNF receptor superfamily 1A and 1B, IL-6R) in PM, with OB group showing less pronounced chemoattracting and proinflammatory profile compared to T2DM group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_provenance.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion evidence source_evidence_literature NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_provenance.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion SIO_000772 21289263 NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_provenance.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion wasDerivedFrom befree-20150227 NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_provenance.
- NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_assertion wasGeneratedBy ECO_0000203 NP297537.RA9RqD-51d8tHrp7oreD8_SFUe6WjWLNBJpyyRK8eSeLc130_provenance.